More than 9,000 lawsuits have been filed against American Home Products, maker of fenfluramine, the fen in the fen-phen diet drug combination.
The company pulled Pondimin and Redux off the market in 1997 after a Mayo Clinic study linked fenfluramine to potentially fatal heart valve damage.
 American Home Products has agreed to pay $ 3.75 billion to settle thousands of lawsuits filed nationwide by people claiming health problems due to the company's once popular fen-phen diet drug combination, the company announced today.
 The first trial over heart-valve damage from fen-phen has ended in a reported $ 500,000 settlement for a woman who used the diet drug combination.
The Madison, N.J.-based drug maker pulled fenfluramine and Redux off the market in 1997 at the Food and Drug Administration's request after a Mayo Clinic study linked the drugs to potentially fatal heart valve damage.
American Home Products sold the fen half of the combination under the brand name Pondimin, and made Pondimin's chemical cousin Redux.
The second drug in the combination, phentermine, is still on the market.
Lawyers for Ms. Moore said American Home Products knew fen-phen caused serious heart problems and underreported the number of cases of primary pulmonary hypertension.
 PHILADELPHIA AP A federal judge has approved the proposed $ 3.75 billion national settlement of health claims stemming from the diet drug combination fen-phen, which has been linked to potentially fatal heart valve damage.
